Stock Ratings / Health Care / INSP / earnings

LMAT (74) XRAY (46) UFPT (81) KMTS (43) ⌘ Pro Terminal →

Inspire Medical Systems Inc. (INSP) Next Earnings Date & Expected ±8% Move

$71.18 +0.30% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $71.08

Inspire Medical Systems Inc. (INSP) carries a Roarable Rating of C- (Hold) with 61/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

📊 Historical Track Record: Scores of 61/100 (C-) historically posted market-perform odds over rolling 90-day windows (+0.5% avg 90D alpha vs SPY) →

ROARABLE C- • HOLD / WATCH Cap $2.06B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $71.08 (-0.14%)🧬 Cannibal Buyback (-2.36% YoY Shares)⚙️ Cash Engine: 8/20 (D-) • 8.6% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 61/100 (C-) historically posted market-perform odds over rolling 90-day windows (+0.5% avg 90D alpha vs SPY • 53.9% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERHOLD / WATCH • C-

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk B-

Each axis scored 0–20

12M PRICE TARGET CONE+1.3% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for INSP)Realized 20D OHLCV Swing Band: ±8%

Deterministic 5-Pillar Attribution (61/100 Composite)

🔍 WHY INSP SCORES 61/100 (C-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+18/20 pts (30% of score)

Altman Z-Score 11.40 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▲ #2 Bullish Driver: Insider Conviction & Share Dilution+16/20 pts (26% of score)

SEC Form 4 / 13F Thermometer: 80% Net Buy • Cannibal Buyback (-2.36% YoY Shares)

▼ #1 Drag / Risk Factor: Cash Engine Quality8/20 pts (-12 pt drag)

Capital intensity & 5.6% operating margin leave 12 pts on the table

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C-$68.89-0.1% Next Q

Q2 (-2Q)

Grade C$68.79+3.4% Next Q

Q3 (-1Q)

Grade C$71.11+0.1% Next Q

Current

Grade C-$71.18+0.5% Hist 90D α

Trajectory: C- (53) → C- (61)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the INSP Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 61/100 (C-) score, INSP faces multiple-compression risk if 14.2x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Sensitive to high interest rates and tighter Federal Reserve market liquidity.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.36% YoY Shares) — any gross margin slip below 82.9% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($68.59) or 200D SMA ($58.57) invalidates the momentum regime and cuts Target Base ($72.14) toward Bear Floor ($56.27).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $INSP• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “INSP Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 61%NO 39%Trade / Inspect Odds →

NEXT EST. WINDOW: Dec 30, 2026 (~58 DAYS)

Historical OHLCV Volatility ±8% Swing Band

±$5.69 Expected Swing

MODEL EARNINGS SETUP GAUGE

INSP Quantitative Pre-Earnings Setup: 61/100

Trailing EPS: $5.03 • YoY Revenue Growth: 13.6%

Model Bullish Setup (61/100)Model Risk Weight (39/100)

Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).

LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

Period	Filed	Revenue	Net Profit	Free Cash Flow	Gross Margin
FY 2025	2025-12-31	$912.0M	$145.4M	$78.5M	85.4%
FY 2024	2024-12-31	$802.8M	$53.5M	$91.1M	84.7%
FY 2023	2023-12-31	$624.8M	-$21.2M	$24.7M	85.4%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Options & Swing Structure Desk

Whale Flow & Momentum Playbook: Evaluating INSP & AI Leaders Without Chasing Tops

✓Institutional whale strikes & implied earnings move audit on INSP
✓How disciplined traders manage risk using pre-published trigger & invalidation levels
✓Includes nightly RQD rating-change & forensic signal email alerts on tracked leaders

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

INSP // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +26.79%🛡️ HOLDING TREND SUPPORT

2026-10-30O $70.63H $71.19L $67.80C $71.18VOL 796.4K

RES: $90.60SUP: $70.06SMA50: $68.59SMA200: $58.57

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

INSP Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 INSP Butterfly Map → + Track INSP →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

6.0%/yr Implied 5Y Growth

vs. +13.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on INSP today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for INSP. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for INSP today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (INSP)

Health Care Rank #183 of 1016 ⚔️ LMAT vs INSP Full Matrix →

1. Head-to-Head Health Care Peer Comparison (INSP vs. LMAT, XRAY, UFPT, KMTS)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Inspire Medical Systems Inc. (INSP) ranks #183 by composite RQD confidence (61/100, grade C-) and #256 by equity capitalization ($2.06B). Within this direct 5-issuer industry benchmark cohort, INSP leads on earnings valuation at 14.2x trailing P/E, while LMAT leads on capital efficiency and profitability with 14.7% ROIC and 71.5% gross margin. UFPT currently holds the highest overall quantitative score in the immediate peer group at 81/100 (A-) compared with INSP at 61/100 (C-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
INSP ACTIVE Inspire Medical Systems Inc.	C-	61/100	14.2x	85.4%	6.0%	+0.30%	$2.06B	Benchmark Subject
LMAT LeMaitre Vascular Inc.	B	74/100	33.8x	71.5%	14.7%	+2.90%	$1.95B	/lmat-vs-insp →
XRAY DENTSPLY SIRONA Inc.	D	46/100	—	50.0%	-11.0%	+1.80%	$1.92B	/xray-vs-insp →
UFPT UFP Technologies Inc.	A-	81/100	33.3x	28.3%	13.9%	+2.55%	$2.27B	/ufpt-vs-insp →
KMTS Kestra Medical Technologies Ltd.	D-	43/100	—	51.4%	-35.0%	+2.48%	$1.82B	/kmts-vs-insp →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001609550

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Inspire Medical Systems Inc. (INSP) reported GAAP revenue of $912.0M (+13.6% vs. FY2024 revenue of $802.8M , and +46.0% cumulative change since FY2023) , GAAP net income of $145.4M, operating cash flow of $117.0M, and free cash flow of $78.5M (-13.9% YoY). On the balance sheet, INSP closed FY2025 with $907.3M in total assets against $0 in total debt (Altman Z-Score: 11.40, Piotroski F-Score: 7/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$912.0M	$145.4M	$117.0M	$78.5M	$907.3M	—
FY2024 (FY)	2024-12-31	$802.8M	$53.5M	$130.2M	$91.1M	$808.4M	—
FY2023 (FY)	2023-12-31	$624.8M	-$21.2M	$24.7M	$24.7M	—	—

3. INSP Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is INSP stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Inspire Medical Systems Inc. (NYSE: INSP) is rated C- (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 61/100 at a spot price of $71.18 (+0.30% 1D, market cap $2.06B). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 18/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 16/20. Across 1016 tracked Health Care issuers, INSP ranks #183 in composite RQD confidence.

How does INSP compare to LMAT and XRAY in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), INSP carries a Roarable C- (61/100 RQD), trailing P/E of 14.2x, gross margin of 85.4%, and ROIC of 6.0%. By comparison, LMAT (LeMaitre Vascular Inc.) holds a B grade (74/100 RQD, P/E 33.8x, ROIC 14.7%, cap $1.95B) and XRAY (DENTSPLY SIRONA Inc.) posts a D grade (46/100 RQD, P/E N/A, ROIC -11.0%, cap $1.92B). Among the 5-stock peer group, INSP leads on earnings multiple (14.2x) while LMAT leads on capital efficiency (14.7% ROIC).

What are the biggest fundamental strengths and SEC risk factors for INSP?

Per INSP's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001609550), Inspire Medical Systems Inc. generated $912.0M in revenue (+13.6% YoY), $145.4M in net income, and $78.5M in free cash flow against $907.3M in total assets and $0 in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is INSP trading relative to its 50-day, 200-day, and 52-week technical levels?

INSP last traded at $71.18 (+0.30% on volume of 512,603 shares), positioning the stock +3.78% above its 50-day simple moving average ($68.59) and +21.53% above its 200-day simple moving average ($58.57). Across its 52-week range of $38.91 to $147.03, INSP sits at the 29.8% percentile with a 14-day RSI of 45.4 (NEUTRAL RANGE) and an implied next-earnings move of ±8.0% ($65.49 to $76.87).